Frontiers in Immunology · 2018 · 22 citations · 35 references
Life SciencesBiochemistryImmunologyCell SignalingInnate ImmunitySignal TransductionBile SecretionCholestatic Liver InjuryHepatic PathophysiologyLiver DiseaseLiver PhysiologyThioredoxin SystemAnimal Models Of CholestasisAntimicrobial Peptide ActivityCholestasis PathophysiologyConstitutive Androstane Receptor SignalingDefensin ExpressionDefensin FamilyFarnesoid X Receptor SignalingHost Antimicrobial Peptides
Background & Aims: Knowledge about innate antimicrobial defense of the liver is limited. We investigated hepatic expression and regulation of antimicrobial peptides with focus on the human beta defensin-1 (hBD-1). Methods: Radial diffusion assay was used to analyze antimicrobial activity of liver tissue. Different defensins including hBD-1 and its activator thioredoxin-1 (TXN) were analyzed in healthy and cholestatic liver samples by qPCR and immunostaining. Regulation of hBD-1 expression was studied in vitro and in vivo using bile duct ligated mice. Regulation of hBD-1 via bilirubin and bile acids (BAs) was studied using siRNA. Results: We found strong antimicrobial activity of liver tissue against Escherichia coli. As a potential mediator of this antimicrobial activity we detected high expression of hBD-1 and TXN in hepatocytes whereas other defensins were minimally expressed. Using a specific antibody for the reduced, antimicrobially active form of hBD-1 we found hBD-1 in co-localization with TXN within hepatocytes. hBD-1 was upregulated in cholestasis in a graded fashion. In cholestatic mice hepatic AMP expression (Defb-1 and Hamp) was enhanced. Bilirubin and BAs were able to induce hBD-1 in hepatic cell cultures in vitro. Treatment with siRNA and/or agonists demonstrated that the farnesoid X receptor (FXR) mediates basal expression of hBD-1, whereas both CAR (constitutive androstane receptor) and FXR seem to be responsible for the induction of hBD-1 by bilirubin. Conclusions: hBD-1 is prominently expressed in hepatocytes. It is induced during cholestasis through bilirubin and BAs, mediated by CAR and especially FXR. Reduction by TXN activates hBD-1 to a potential key player in innate antimicrobial defense of the liver.
35
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
Frederik Nevens, Pietro Andreoné, G. Mazzella et al. · New England Journal of Medicine · 2016 · 1.1K citations · Full text
Paneth cell trypsin is the processing enzyme for human defensin-5
Dipankar Ghosh, Edith Porter, Bo Shen et al. · Nature Immunology · 2002 · 426 citations